Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04849728
What this trial is testing

Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Inventiva Pharma 1,000
Not applicableLooking for participantsNCT05842850
What this trial is testing

Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals

Who this might be right for
NAFLD
Steno Diabetes Center Copenhagen 8
Not applicableEnrolling By InvitationNCT07452744
What this trial is testing

Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver Disease
Bioagile Therapeutics Pvt. Ltd. 170
Not applicableStudy completedNCT06031532
What this trial is testing

Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver Patients
Sohag University 110
Testing effectiveness (Phase 2)Study completedNCT04521114
What this trial is testing

Leronlimab (PRO 140) in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
CytoDyn, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT03042767
What this trial is testing

Anti-LPS Antibody Treatment for Pediatric NAFLD

Who this might be right for
Nonalcoholic Fatty Liver Disease (NAFLD)
Miriam Vos, MD 40
Not applicableUnknownNCT02124577
What this trial is testing

Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of California, San Diego 50
Not applicableStudy completedNCT05419765
What this trial is testing

Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Roma La Sapienza 316
Not applicableStudy completedNCT02148471
What this trial is testing

Fatty Acids, Genes and Microbiota in Fatty Liver

Who this might be right for
Nonalcoholic Fatty Liver DiseaseSteatosisNonalcoholic Steatohepatitis
Johane Allard 205
Not applicableStudy completedNCT03211299
What this trial is testing

Determinants of Liver Fat Composition

Who this might be right for
Fatty Liver, NonalcoholicInsulin Sensitivity
Maastricht University Medical Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Not applicableUnknownNCT03156881
What this trial is testing

Global Osteopathic Treatment for Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Jenna Wilcox 48
Not applicableNot Yet RecruitingNCT05857319
What this trial is testing

Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)

Who this might be right for
Overweight and ObesityCardiovascular DiseasesMetabolic Disease+4 more
Groupe Éthique et Santé 10,000
Not applicableStudy completedNCT01264198
What this trial is testing

The Role of Resistance Training in Non Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD (Non-Alcoholic Fatty Liver Disease)Resistance Training
Tel-Aviv Sourasky Medical Center 82
Testing effectiveness (Phase 2)UnknownNCT05084404
What this trial is testing

Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Yokohama City University 29
Not applicableStudy completedNCT04281121
What this trial is testing

Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver

Who this might be right for
Fatty Liver
Ain Shams University 60
Early research (Phase 1)Study completedNCT04193436
What this trial is testing

COMPARE THE PHARMACOKINETICS OF PF-06835919 IN PARTICIPANTS WITH AND WITHOUT HEPATIC IMPAIRMENT

Who this might be right for
Hepatic ImpairmentHealthy Participants
Pfizer 23
Large-scale testing (Phase 3)Looking for participantsNCT06493799
What this trial is testing

In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop

Who this might be right for
Chronic Liver Disease
Green Cross Wellbeing 226
Testing effectiveness (Phase 2)Study completedNCT06482112
What this trial is testing

Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (MK-6024-016)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNon-alcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease+1 more
Merck Sharp & Dohme LLC 124
Not applicableStudy completedNCT05309642
What this trial is testing

Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Ewha Womans University Mokdong Hospital 72
Next Page